Association of Medicaid expansion with 1-year mortality among patients with end-stage renal disease
JAMA Dec 08, 2018
Swaminathan S, et al. - Among 236,246 nonelderly patients with end-stage renal disease (ESRD) initiating dialysis, researchers investigated the relationship of Medicaid expansion with 1-year mortality. Findings revealed that living in a state that expanded Medicaid under the Affordable Care Act was related to lower 1-year mortality among patients with ESRD initiating dialysis.
Methods
Go to Original
- From January 2011 to March 2017, difference-in-differences analysis of nonelderly patients initiating dialysis in Medicaid expansion and nonexpansion states.
- Exposure included living in a Medicaid expansion state.
- One-year mortality was the primary outcome.
- Insurance, predialysis nephrology care, and type of vascular access for hemodialysis were included secondary outcomes.
- In total, there were 142,724 patients in expansion states (mean age, 50.2 years; 40.2% female) and 93,522 patients in non-expansion states (mean age, 49.7; 42.4% female).
- One-year mortality following dialysis initiation declined from 6.9% in the preexpansion period to 6.1% after expansion (change, −0.8 percentage points; 95% CI, −1.1 to −0.5) in Medicaid expansion states.
- Mortality rates in non-expansion states were 7.0% before expansion and 6.8% after expansion (change, −0.2 percentage points; 95% CI, −0.5 to 0.2), resulting in an adjusted absolute mortality reduction in expansion states of −0.6 percentage points (95% CI, −1.0 to −0.2).
- It was observed that mortality reductions were largest for black patients (−1.4 percentage points; 95% CI, −2.2, −0.7; P=.04 for interaction) and patients aged 19 to 44 years (−1.1 percentage points; 95% CI, −2.1 to −0.3; P=.01 for interaction).
- Findings suggested an association of expansion with a 10.5-percentage-point (95% CI, 7.7-13.2) increase in Medicaid coverage at dialysis initiation, a −4.2-percentage-point (95% CI, −6.0 to −2.3) decrease in being uninsured, and a 2.3-percentage-point (95% CI, 0.6-4.1) increase in the presence of an arteriovenous fistula or graft.
- Changes in care for predialysis nephrology have not been significant.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries